“PSA-itis”: Knowledge of Serum Prostate Specific Antigen and Other Causes of Anxiety in Men with Metastatic Prostate Cancer
- 1 December 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (6) , 2516-2520
- https://doi.org/10.1016/s0022-5347(05)64180-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Eradication of a disease: how we cured symptomless prostate cancerThe Lancet, 2002
- Convergent Discriminitive, and Predictive Validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) Assessment and Comparison with Analogous Scales From the EORTC QLQ-C30 and a Trial-Specific ModuleJournal of Clinical Epidemiology, 1999
- Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate CancerJNCI Journal of the National Cancer Institute, 1999
- Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.Journal of Clinical Oncology, 1998
- Responsiveness to Change in Health-Related Quality of Life in a Randomized Clinical Trial: A Comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with Analogous Scales from the EORTC QLQ-C30 and a Trial Specific ModuleJournal of Clinical Epidemiology, 1998
- PSAdynia and other PSA-related syndromes: A new epidemic—A case history and taxonomyUrology, 1997
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markersUrology, 1986
- Quality of Life Measurements in Patients with Malignant Disease: A ReviewJournal of the Royal Society of Medicine, 1986
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983